BioCentury
ARTICLE | Financial News

ImmunoCellular adds $21M

October 19, 2012 1:28 AM UTC

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC) raised $21 million through the sale of 10 million shares at $2.10 in a follow-on underwritten by Lazard; Roth Capital Partners; Maxim; and Summer Street....